Case Report: Hyperbilirubinemia in Gilbert Syndrome Attenuates Covid-19-Induced Metabolic Disturbances
暂无分享,去创建一个
Ali I. Al-Gareeb | N. Cruz-Martins | G. Batiha | Hayder M Al-Kuraishy | S. Abdullah | H. Al-kuraishy | A. Al-Gareeb | Hayder M. Al-kuraishy
[1] Zeming Liu,et al. Bilirubin Levels as Potential Indicators of Disease Severity in Coronavirus Disease Patients: A Retrospective Cohort Study , 2020, Frontiers in Medicine.
[2] Y. Jeong,et al. The Anti-Inflammatory Role of Bilirubin on “Two-Hit” Sepsis Animal Model , 2020, International journal of molecular sciences.
[3] Steven P. Keller,et al. Emerging Mechanisms of Pulmonary Vasoconstriction in SARS-CoV-2-Induced Acute Respiratory Distress Syndrome (ARDS) and Potential Therapeutic Targets , 2020, International journal of molecular sciences.
[4] J. P. de Rivero Vaccari,et al. The Inflammasome in Times of COVID-19 , 2020, Frontiers in Immunology.
[5] H. Goyal,et al. Pulmonary and Extra-Pulmonary Clinical Manifestations of COVID-19 , 2020, Frontiers in Medicine.
[6] J. Taneera,et al. Expression Profile of SARS-CoV-2 Host Receptors in Human Pancreatic Islets Revealed Upregulation of ACE2 in Diabetic Donors , 2020, Biology.
[7] K. Sklinda,et al. COVID-19 severity scoring systems in radiological imaging – a review , 2020, Polish journal of radiology.
[8] Kai Yin,et al. Bilirubin in metabolic syndrome and associated inflammatory diseases: New perspectives. , 2020, Life sciences.
[9] Hayder M Al-Kuraishy,et al. Macrolides and COVID-19: An optimum premise , 2020 .
[10] L. García,et al. Immune Response, Inflammation, and the Clinical Spectrum of COVID-19 , 2020, Frontiers in Immunology.
[11] D. Ragab,et al. The COVID-19 Cytokine Storm; What We Know So Far , 2020, Frontiers in Immunology.
[12] N. Soudani,et al. Molecular Insights Into SARS COV-2 Interaction With Cardiovascular Disease: Role of RAAS and MAPK Signaling , 2020, Frontiers in Pharmacology.
[13] N. Liu,et al. High rate of increased level of plasma Angiotensin II and its gender difference in COVID-19: an analysis of 55 hospitalized patients with COVID-19 in a single hospital, WuHan, China , 2020, medRxiv.
[14] M. Lila,et al. In Vitro Evaluation of a Novel Synthetic Bilirubin Analog as an Antioxidant and Cytoprotective Agent for Pancreatic Islet Transplantation , 2020, Cell transplantation.
[15] W. Brady,et al. Cardiovascular complications in COVID-19 , 2020, The American Journal of Emergency Medicine.
[16] M. Moustaki,et al. Gilbert syndrome. , 2020, European journal of pediatrics.
[17] Ji‐Hyun Lee,et al. Serum bilirubin level is associated with exercise capacity and quality of life in chronic obstructive pulmonary disease , 2019, Respiratory Research.
[18] Baojian Wu,et al. Bilirubin alleviates alum-induced peritonitis through inactivation of NLRP3 inflammasome. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[19] T. Hinds,et al. Bilirubin, a Cardiometabolic Signaling Molecule , 2018, Hypertension.
[20] A. Bulmer,et al. Chronically elevated bilirubin protects from cardiac reperfusion injury in the male Gunn rat , 2017, Acta physiologica.
[21] R. Tsang,et al. Oncology Drug Dosing in Gilbert Syndrome Associated with UGT1A1: A Summary of the Literature , 2017, Pharmacotherapy.
[22] A. Tanaka,et al. Gilbert Syndrome with Concomitant Hereditary Spherocytosis Presenting with Moderate Unconjugated Hyperbilirubinemia , 2017, Internal medicine.
[23] HirofumiTomiyama,et al. Hyperbilirubinemia, Augmentation of Endothelial Function, and Decrease in Oxidative Stress in Gilbert Syndrome , 2012 .
[24] G. Fadda,et al. Bilirubin: An Endogenous Molecule with Antiviral Activity in vitro , 2012, Front. Pharmacol..
[25] N. Liu. High rate of increased level of plasma Angiotensin II and its gender difference in COVID-19: an analysis of 55 hospitalized patients with COVID-19 in a single hospital, WuHan, China , 2020 .
[26] Dennis Andersson,et al. A retrospective cohort study , 2018 .
[27] P. Smaglik,et al. New Perspectives , 2011, Hormone Research in Paediatrics.
[28] A. Cunliffe. A SUMMARY OF THE LITERATURE , 1924 .